Personalized pulmonary vein isolation guided by left atrial wall thickness for persistent atrial fibrillation ablation: the PeAF-by-LAWT randomized trial.

IF 7.4 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Europace Pub Date : 2025-08-06 DOI:10.1093/europace/euaf163
Giulio Falasconi, Diego Penela, David Soto-Iglesias, Alessia Chiara Latini, Federico Landra, Emanuele Curti, Pietro Francia, Andrea Saglietto, Dario Turturiello, Daniel Viveros, Aldo Bellido, Jose Alderete, Fatima Zaraket, Paula Franco, Stefano Valcher, Francesco Amata, Chiara Valeriano, Carlo Gigante, Lucio Teresi, Bruno Tonello, Roberta Mea, Lautaro Sánchez-Mollá, Carmine De Lucia, Marina Huguet, Óscar Cámara, José-Tomás Ortiz-Pérez, Julio Martí-Almor, Antonio Berruezo
{"title":"Personalized pulmonary vein isolation guided by left atrial wall thickness for persistent atrial fibrillation ablation: the PeAF-by-LAWT randomized trial.","authors":"Giulio Falasconi, Diego Penela, David Soto-Iglesias, Alessia Chiara Latini, Federico Landra, Emanuele Curti, Pietro Francia, Andrea Saglietto, Dario Turturiello, Daniel Viveros, Aldo Bellido, Jose Alderete, Fatima Zaraket, Paula Franco, Stefano Valcher, Francesco Amata, Chiara Valeriano, Carlo Gigante, Lucio Teresi, Bruno Tonello, Roberta Mea, Lautaro Sánchez-Mollá, Carmine De Lucia, Marina Huguet, Óscar Cámara, José-Tomás Ortiz-Pérez, Julio Martí-Almor, Antonio Berruezo","doi":"10.1093/europace/euaf163","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>A personalized pulmonary vein isolation(PVI) approach aimed at ablation index(AI)titration according to MDCT-derived left atrial wall thickness(LAWT) maps reported high effectiveness and efficiency outcomes for persistent atrial fibrillation(PeAF) ablation. To date, no randomized trials have compared this approach with the standard CLOSE protocol.</p><p><strong>Objectives: </strong>This non-inferiority randomized controlled trial sought to compare a LAWT-guided PVI with CLOSE protocol-based for PeAF(NCT05396534). Primary endpoint was freedom from atrial arrhythmias recurrence. Secondary endpoints were major complication rate, procedure time, radiofrequency time, and first-pass PVI rate.</p><p><strong>Methods: </strong>Consecutive patients referred for first-time PeAF ablation were randomized on a 1:1 basis. In the by-LAWT arm, the AI was titrated according to local LAWT, and the ablation line was personalized to avoid the thickest regions at PV antrum. In the CLOSE arm, LAWT information was not available to the operator; the ablation was performed according to the CLOSE study settings: AI ≥400 at the posterior wall and ≥550 at the anterior wall.</p><p><strong>Results: </strong>156 patients were included. At 12-month follow-up, no significant difference occurred in atrial arrhythmia-free survival between groups(p=0.50). In the by-LAWT group a significant reduction in procedure time(60.5vs.80.0 minutes; p<0.01) and RF time(14.4vs.28.6 minutes; p<0.01) was observed. No difference was observed regarding first-pass PVI(p=0.72) and major complication rate(p=0.99).</p><p><strong>Conclusions: </strong>The PeAF-by-LAWT trial is the first prospective randomized study to demonstrate that a personalized LAWT-guided PVI for PeAF ablation is non-inferior to the standard CLOSE protocol in terms of arrhythmia-free survival, while significantly improving procedural efficiency. The study was not powered to detect differences in safety outcomes.</p>","PeriodicalId":11981,"journal":{"name":"Europace","volume":" ","pages":""},"PeriodicalIF":7.4000,"publicationDate":"2025-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Europace","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/europace/euaf163","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: A personalized pulmonary vein isolation(PVI) approach aimed at ablation index(AI)titration according to MDCT-derived left atrial wall thickness(LAWT) maps reported high effectiveness and efficiency outcomes for persistent atrial fibrillation(PeAF) ablation. To date, no randomized trials have compared this approach with the standard CLOSE protocol.

Objectives: This non-inferiority randomized controlled trial sought to compare a LAWT-guided PVI with CLOSE protocol-based for PeAF(NCT05396534). Primary endpoint was freedom from atrial arrhythmias recurrence. Secondary endpoints were major complication rate, procedure time, radiofrequency time, and first-pass PVI rate.

Methods: Consecutive patients referred for first-time PeAF ablation were randomized on a 1:1 basis. In the by-LAWT arm, the AI was titrated according to local LAWT, and the ablation line was personalized to avoid the thickest regions at PV antrum. In the CLOSE arm, LAWT information was not available to the operator; the ablation was performed according to the CLOSE study settings: AI ≥400 at the posterior wall and ≥550 at the anterior wall.

Results: 156 patients were included. At 12-month follow-up, no significant difference occurred in atrial arrhythmia-free survival between groups(p=0.50). In the by-LAWT group a significant reduction in procedure time(60.5vs.80.0 minutes; p<0.01) and RF time(14.4vs.28.6 minutes; p<0.01) was observed. No difference was observed regarding first-pass PVI(p=0.72) and major complication rate(p=0.99).

Conclusions: The PeAF-by-LAWT trial is the first prospective randomized study to demonstrate that a personalized LAWT-guided PVI for PeAF ablation is non-inferior to the standard CLOSE protocol in terms of arrhythmia-free survival, while significantly improving procedural efficiency. The study was not powered to detect differences in safety outcomes.

在左房壁厚度指导下个体化肺静脉隔离治疗持续性房颤消融:PeAF-by-LAWT随机试验
背景:根据mdct衍生的左房壁厚度(LAWT)图,一种针对消融指数(AI)滴定的个性化肺静脉隔离(PVI)方法报道了持续性心房颤动(PeAF)消融的高有效性和高效率结果。迄今为止,尚无随机试验将该方法与标准CLOSE方案进行比较。目的:这项非劣效性随机对照试验旨在比较lawt指导的PVI与基于CLOSE方案的PeAF(NCT05396534)。主要终点为房性心律失常不再复发。次要终点为主要并发症发生率、手术时间、射频时间和首次通过PVI率。方法:首次行PeAF消融的连续患者按1:1的比例随机分组。在副LAWT组,根据局部LAWT滴定AI,个性化消融线以避开PV窦腔最厚的区域。在CLOSE臂中,操作员无法获得LAWT信息;根据CLOSE研究设置进行消融:后壁AI≥400,前壁AI≥550。结果:纳入156例患者。随访12个月,两组无房性心律失常生存率无统计学差异(p=0.50)。在by-LAWT组中,手术时间显著减少(60.5vs.80.0分钟;结论:PeAF-by- lawt试验是首个前瞻性随机研究,证明在PeAF消融中,个性化lawt引导的PVI在无心律失常生存方面不逊色于标准CLOSE方案,同时显著提高了程序效率。该研究没有能力检测安全结果的差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Europace
Europace 医学-心血管系统
CiteScore
10.30
自引率
8.20%
发文量
851
审稿时长
3-6 weeks
期刊介绍: EP - Europace - European Journal of Pacing, Arrhythmias and Cardiac Electrophysiology of the European Heart Rhythm Association of the European Society of Cardiology. The journal aims to provide an avenue of communication of top quality European and international original scientific work and reviews in the fields of Arrhythmias, Pacing and Cellular Electrophysiology. The Journal offers the reader a collection of contemporary original peer-reviewed papers, invited papers and editorial comments together with book reviews and correspondence.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信